Inactive Instrument

HELX ACQU

HLXA

KYG4444C1024

Helix Acquisition Corp. will Change its Name to MoonLake Immunotherapeutics

April 06, 2022 at 12:00 am EDT

Effective April 06, 2022, Helix Acquisition Corp. will change its name to MoonLake Immunotherapeutics.

Latest news about HELX ACQU

Helix Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Helix Acquisition Corp. will Change its Name to MoonLake Immunotherapeutics	22-04-06	CI
Helix Acquisition Corp.(NasdaqCM:HLXA) dropped from NASDAQ Composite Index	22-04-05	CI
MoonLake Immunotherapeutics AG completed the acquisition of Helix Acquisition Corp. from a group of shareholders in a reverse merger transaction.	22-04-04	CI
Helix Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-17	CI
Helix Acquisition Corp. Auditor Raises 'Going Concern' Doubt	22-02-16	CI
Helix Acquisition Corp. Auditor Raises 'Going Concern' Doubt	21-12-13	CI
Helix Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
Helix Acquisition : MoonLake to Merge with SPAC Helix Acquisition to Go Public	21-10-04	MT
MoonLake Immunotherapeutics AG signed a non-binding letter of intent to acquire Helix Acquisition Corp. from a group of shareholders for approximately $350 million in a reverse merger transaction.	21-10-03	CI
Helix Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
Helix Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-21	CI
Helix Acquisition Corp. Announces Management Changes	21-05-03	CI
Certain Class B Ordinary Shares of Helix Acquisition Corp. are subject to a Lock-Up Agreement Ending on 19-APR-2021.	21-04-18	CI
Helix Acquisition Corp. Announces Executive Changes	20-10-22	CI
Helix Acquisition Corp.(NasdaqCM:HLXA) added to NASDAQ Composite Index	20-10-21	CI
Helix Acquisition Corp. has completed an IPO in the amount of $100 million.	20-10-19	CI
Helix Acquisition Corp. has filed an IPO in the amount of $100 million.	20-10-01	CI

Helix Acquisition Corp is a blank check company. The Company is incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company is primarily focused on the healthcare industry.

Sector

More about the company

HELX ACQU

Equities

HLXA

KYG4444C1024

Helix Acquisition Corp. will Change its Name to MoonLake Immunotherapeutics

Latest news about HELX ACQU

Chart HELX ACQU

Company Profile